首页> 美国卫生研究院文献>Respiratory Research >Erratum to: A randomized seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

【2h】

Erratum to: A randomized seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

机译：勘误：一项为期7天的随机研究评估使用新型Co-Suspension™输送技术的格隆溴铵/福莫特罗富马酸酯固定剂量联合计量吸入器对中度至重度慢性阻塞性肺疾病患者的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Respiratory Research
作者
Colin Reisner; Leonardo M. Fabbri; Edward M. Kerwin; Charles Fogarty; Selwyn Spangenthal; Klaus F. Rabe; Gary T. Ferguson; Fernando J. Martinez; James F. Donohue; Patrick Darken; Earl St. Rose; Chad Orevillo; Shannon Strom; Tracy Fischer; Michael Golden; Sarvajna Dwivedi;
展开▼
作者单位

展开▼
年(卷),期 2017(18),-1
年度 2017
页码 158
总页数 3
原文格式 PDF
正文语种
中图分类呼吸生理学;
关键词

相似文献

外文文献
专利

1. Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension (TM) Delivery Technology in patients with chronic obstructive pulmonary disease [J] . Hanania Nicola A., Tashkin Donald P., Kerwin Edward M., Respiratory medicine . 2017,第期

机译：使用新型共悬浮（TM）递送技术慢性阻塞性肺病患者使用新型共悬浮（TM）递送技术的长期安全性和疗效。
2. An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease [J] . Krishna Pudi, Gregory Feldman, Faisal Fakih, Journal of aerosol medicine and pulmonary drug delivery . 2019,第1期

机译：一种开放标签研究，评估剂量指示剂在中度至关重要慢性阻塞性肺疾病患者中递送甘氨酸和蛋白质吸入剂的计量吸入器中的性能
3. A phase III study of triple therapy with budesonide/glycopyrrolate/ formoterol fumarate metered dose inhaler 320/18/9.6 mu g and 160/18/9.6 mu g using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol [J] . Rabe Klaus F., Martinez Fernando J., Ferguson Gary T., Respiratory medicine . 2019,第期

机译：使用共悬浮递送技术在中度至极其严重的COPD中使用共悬浮递送技术的三相治疗三重治疗三重治疗的研究协议
4. Efficacy of DVD technology in chronic obstructive pulmonary disease self-management education of rural patients [D] . Stellefson, Michael Leland 2008

机译：DVD技术在农村地区慢性阻塞性肺疾病自我管理教育中的作用
5. A randomized seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease [O] . Colin Reisner, Leonardo M. Fabbri, Edward M. Kerwin, 2017

机译：一项为期7天的随机研究使用新型Co-Suspension™递送技术评估格隆溴铵/富马酸福莫特罗固定剂量联合剂量吸入器对中度至重度慢性阻塞性肺疾病患者的疗效和安全性
6. A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease [O] . 2017

机译：一项为期7天的随机研究，使用新型Co-Suspension™递送技术评估格隆溴铵/富马酸福莫特罗固定剂量联合剂量吸入器对中度至重度慢性阻塞性肺疾病患者的疗效和安全性

Erratum to: A randomized seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

著录项

相似文献

相关主题

期刊订阅